Pharmaceutical Technology Europe, Jun 1, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Jun 1, 2012
Packaging Forum
New Technologies Displayed at INTERPHEX
By Hallie Forcinio
Our Packaging Forum editor reports on the infamous US trade show, INTERPHEX. Highlights included the latest in pharmaceutical packaging equipment, containers and labels, as well as new capabilities among contract service providers.
Peer-Reviewed Research
Freeze-Drying Process Optimisation for a Small Molecule
By Henning Gieseler, PhD , Susanne Hibler
For true freeze-drying cycle optimisation, information on the maximum allowable product temperature during primary drying is required.
Interview
Is Pharma Getting the Best out of Social Media?
By Bhaskar Sambasivan
With social media receiving increased focus as the pharma industry strives to make the most of new communication technologies, we speak with Cognizant's Bhaskar Sambasivan to find out where pharma is when it comes to social media implementation and what more should be being done.
Ingredients
Peptides Gain Traction in Drug Development
By Patricia Van Arnum
Although representing a small part of overall drug development, peptides and related technologies to improve their production are making inroads.
Analytical
Preclinical Dose-Formulation Stability
By Amy Smith , Melissa Whitsel
A number of factors need to be considered when evaluating preclinical dose-formulation stability. The authors discuss formulation, storage and dosing conditions.
Ask the Expert
Bolstering UK Pharma with a Patent Box
By Nick Beckett
Nick Beckett from the UK law firm CMS Cameron McKenna explains how the UK government's proposed Patent Box legislation may impact the pharmaceutical sector.
Industry Insider
European regulators Struggle with Globalisation of Clinical Trials
By Nathan Jessop
The globalisation of clinical trials is putting pressure on the European Medicines Agency.
Outsourcing Review
Biomanufacturing Innovation
By Eric Langer
The industry wants more innovation, but can suppliers meet customers' needs?
News
News
By Stephanie Sutton
Pharma Aid for Developing World
Editor's Comment
Welcome!
By Jo Watts
It is with real pleasure that I join the Pharmaceutical Technology Europe (PTE) team.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here